The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis

Nature Communications

Volumn 5, Issue , 2014, Pages

  Lande, Roberto ^a,b   Botti, Elisabetta ^c   Jandus, Camilla ^d   Dojcinovic, Danijel ^e   Fanelli, Giorgia ^c   Conrad, Curdin ^b   Chamilos, Georgios ^f   Feldmeyer, Laurence ^b   Marinari, Barbara ^g   Chon, Susan ^h   Vence, Luis ^f   Riccieri, Valeria ^c   Guillaume, Phillippe ^e   Navarini, Alex A ⁱ   Romero, Pedro ^e   Costanzo, Antonio ^c,d   Piccolella, Enza ^c   Gilliet, Michel ^b   Frasca, Loredana ^a,b  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d UNIVERSITY OF LAUSANNE   (Switzerland)

^e TC Metrix ^*  (Switzerland)

^f UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^g UNIVERSITY OF ROME TOR VERGATA   (Italy)

^h University of Texas Health Science Center at Houston   (United States)

ⁱ UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; GAMMA INTERFERON; GRANZYME B; INTERLEUKIN 8; PERFORIN; T LYMPHOCYTE ANTIGEN; AUTOANTIGEN; CATHELICIDIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE;

ADAPTATION; ANTIGEN; ANTIMICROBIAL ACTIVITY; IMMUNITY; PATHOGENICITY; PEPTIDE; SKIN DISORDER;

ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DISEASE SEVERITY; EPITOPE MAPPING; HUMAN; PSORIASIS; PSORIASIS VULGARIS; T LYMPHOCYTE ACTIVATION; CASE CONTROL STUDY; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; SEVERITY OF ILLNESS INDEX; T LYMPHOCYTE;

AUTOANTIGENS; CASE-CONTROL STUDIES; CATHELICIDINS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; HUMANS; IMMUNOHISTOCHEMISTRY; PSORIASIS; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTES;

EID: 84922704299     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms6621     Document Type: Article

References (70)

1. Lowes, M. A., Bowcock, A. M. & Krueger, J. G. Pathogenesis and therapy of psoriasis. Nature 445, 866-873 (2007).
2. Nestle, F. O., Kaplan, D. H. & Barker, J. Psoriasis. New Engl. J. Med. 361, 496-508 (2009).
3. Griffiths, C. E. & Barker, J. Pathogenesis and clinical features of psoriasis. Lancet 370, 263-271 (2007).
4. Uyemura, K., Yamamura, M., Fivenson, D. F., Modlin, R. L. & Nickoloff, B. J. The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T helper type 1 cell-mediated response. J. Invest. Dermatol. 101, 701-705 (1993).
5. Lowes, M. A. et al. Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J. Invest. Dermatol. 128, 1207-1211 (2008).
6. Zaba, L. C. et al. Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses. J. Exp. Med. 204, 3183-3194 (2007).
7. Zheng, Y. et al. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445, 648-651 (2007).
8. Boyman, O. et al. Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-alpha. J. Exp. Med. 199, 731-736 (2004).
9. Caruso, R. et al. Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis. Nat. Med. 15, 1013-1015 (2009).
10. Nestle, F. O. et al. Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production. J. Exp. Med. 202, 135-143 (2005).
11. Nestle, F. O. et al. Skin immune sentinels in health and disease. Nat. Rev. Immunol. 9, 679-691 (2009).
12. Zanetti, M. Cathelicidins, multifunctional peptides of the innate immunity. J. Leukoc. Biol. 75, 39-48 (2004).
13. Lande, R. et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 449, 564-569 (2007).
14. Ganguly, D. et al. Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8. J. Exp. Med. 206, 1983-1994 (2009).
15. Chamillos, G. et al. Cytosolic sensing of extracellular self-DNA transported into monocytes by the antimicrobial peptide LL37. Blood 120, 3699-3707 (2012).
16. Kim, H. J. et al. LL-37 suppresses sodium nitroprusside-induced apoptosis of systemic sclerosis dermal fibroblasts. Exp. Dermatol. 20, 843-845 (2011).
17. Harder, J. & Schröder, J. M. Psoriatic scales: a promising source for the isolation of human skin-derived antimicrobial proteins. J. Leukoc. Biol. 77, 476-486 (2005).
18. Johnston, A., Gudjonsson, J. E., Sigmundsdottir, H., Love, T. J. & Valdimarsson, H. Peripheral blood T cell responses to keratin peptides that share sequences with streptococcal M proteins are largely restricted to skin-homing CD8() T cells. Clin. Exp. Immunol. 138, 83-93 (2004).
19. Shen, Z., Wang, G., Fan, J. Y., Li, W. & Liu, Y. F. HLA DR B1∗04,∗07-restricted epitopes on Keratin 17 for autoreactive T cells in psoriasis. J. Dermatol. Sci. 38, 25-39 (2005).
20. Sigmundsdottir, H. et al. Circulating T cells of patients with active psoriasis respond to streptococcal M-peptides sharing sequences with human epidermal keratins. Scand. J. Immunol. 45, 688-697 (2007).
21. Valdimarsson, H., Thorleifsdottir, R. H., Sigurdardottir, S. L., Gudjonsson, J. E. & Johnston, A. Psoriasis-as an autoimmune disease caused by molecular mimicry. Trends Immunol. 30, 494-501 (2009).
22. Jin, L. et al. Keratin 17: critical player in the pathogenesis of psoriasis. Med. Res. Rev. 34, 438-454 (2014).
23. Lin, H. H., Zhang, G. L., Tongchusak, S., Reinherz, E. L. & Brusic, V. Evaluation of MHC-II peptide binding prediction servers: applications for vaccine research. BMC Bioinformatics 9(Suppl 12): S22 (2008).
24. Sing, H. & Raghava, G. P. S. ProPred: Prediction of HLA-DR binding sites. Bioinformatics 17, 1236-1237 (2001).
25. Williams, F. et al. High Resolution HLA-DRB1 Identification of a Caucasian Population. Hum. Immunol. 65, 66-77 (2004).
26. Gudjonsson, J. E. et al. Distinct clinical differences between HLA-Cw∗0602 positive and negative psoriasis patients-an analysis of 1019 HLA-C-and HLA-B-typed patients. J. Invest. Dermatol. 126, 4070-4075 (2006).
27. Nair, R. P. et al. Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene. Am. J. Hum. Genet. 78, 827-851 (2006).
28. Gudjonsson, J. E. & Elder, J. T. Psoriasis: epidemiology. Clin. Dermatol. 25, 535-546 (2007).
29. Altman, D. G. Practical Statistic for Medical Research. 610; ISBN 0 412 38620 8 (Chapman and Hall, 1991).
30. Krueger, J. G. et al. IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis. J. Allergy Clin. Immunol. 130, 145-154. e9 (2012).
31. Kryczek, I. et al. Induction of IL-17 T cell trafficking and development by IFN-g: mechanism ad pathological relevance in psoriasis. J. Immunol. 181, 4733-4741 (2008).
32. Mantas, C., Direskeneli, H., Oz, D., Yavuz, S. & Akoglu, T. IL-8 producing cells in patients with Behcet's disease. Clin. Exp. Rheumatol. 18, 249-251 (2000).
33. Schaerli, P. et al. Characterization of human T cells that regulate neutrophilic skin inflammation. J. Immunol. 173, 2151-2158 (2004).
34. Leller, M. et al. T cell-regulated neutrophilic inflammation in autoinflammatory diseases. J. Immunol. 175, 7678-7686 (2005).
35. Betts, M. R. et al. Sensitive and viable identification of antigen-specific CD8 T cells by a flow cytometric assay for degranulation. J. Immunol. Methods 281, 65-78 (2003).
36. Singh, T. P., Lee, C. H. & Farber, J. M. Chemokine receptors in psoriasis. Expert Opin. Ther. Targets 17, 1405-1422 (2013).
37. Gunter, C., Carballido-Perrig, N., Kaesler, S., Carballido, J. M. & Biedermann, T. CXCL16 and CXCR6 are up-regulated in psoriasis and mediate cutaneus recruitment of human CD8 T cells. J. Invest. Dermatol. 132, 626-634 (2012).
38. Sallusto, F., Lenig, D., Förster, R., Lipp, M. & Lanzavecchia, A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401, 708-712 (1999).
39. Conrad, C. et al. Alpha1beta1 integrinis crucial for accumulation of epidermal T cells and the development of psoriasis. Nat. Med. 13, 836-842 (2007).
40. Quadrona, V. et al. CD38 and CD157: a long journey form activation markers to multifunctional molecules. Cytometry 84B, 207-217 (2013).
41. Davidson, A. & Diamond, B. Autoimmune diseases. N. Engl. J. Med. 345, 240-350 (2001).
42. Besgen, P., Trommler, P., Vollmer, S. & Prinz, J. C. Ezrin, maspin, peroxiredoxin 2, and heat shock protein 27: potential targets of a streptococcalinduced autoimmune response in psoriasis. J. Immunol. 184, 5392-5402 (2010).
43. Duhen, T., Geiger, R., Jarrossay, D., Lanzavecchia, A. & Sallusto, F. Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat. Immunol. 10, 857-863 (2009).
44. Ho, P. Y. P. C. et al. Investigating the role of the HLA-Cw6∗02 and HLA-DRB1 genes in susceptibility to psoriatic arthritis: comparison with psoriasis and undifferentiated inflammatory arthritis. Ann. Rheum. Dis. 67, 677-682 (2008).
45. Tewary, P. et al. b-Defensin 2 and 3 promote the uptake of self or CpG DNA, enhance IFN-a production by human plasmacytoid dendritic cells, and promote inflammation. J Immunol. 191, 865-874 (2013).
46. Zaba, L. C. et al. Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes. J. Allergy Clin. Immunol. 124, 1022-10. e1-395 (2009).
47. Antiga, E. et al. Etanercept downregulates the Th17 pathway and decreases the IL-17/IL-10 cell ratio in patients with psoriasis vulgaris. J. Clin. Immunol. 32, 1221-1232 (2012).
48. Mueller, S. N., Gebhardt, T., Carbone, F. R. & Heath, W. R. Memory T cell subsets, migration patterns, and tissue residence. Annu. Rev. Immunol. 31, 137-161 (2013).
49. Lin, W. J., Norris, D. A., Achziger, M., Kotzin, B. L. & Tomkinson, B. Oligoclonal expansion of intraepidermal T cells in psoriasis skin lesions. J. Invest. Dermatol. 117, 1546-1553 (2001).
50. Vollmer, S., Menseen, A. & Prinz, J. C. Dominant lesional T cell receptor rearrangements persist in relapsing psoriasis but are absent from non-lesional skin: evidence for a stable antigen-specific pathogenic T cell response in psoriasis vulgaris. J. Invest. Dermatol. 117, 1296-1301 (2001).
51. Van der Bogaard, E. H. et al. Crosstalk between Keratinocytes and T cells in a 3D microenvironment: A model to study inflammatory skin diseases. J. Invest. Dermatol. 134, 719-727 (2014).
52. Nickoloff, B. J. & Wrone-smith, T. Injection of pre-psoriatic skin with CD4 T cells induces psoriasis. Am. J. Pathol. 155, 145-158 (1999).
53. Bennet, S. R. et al. Help for cytotoxic-T cells responses is mediated by CD40 signalling. Nature 393, 478-480 (2000).
54. Hijnen, D. et al. CD8() T cells in the lesional skin of atopic dermatitis and psoriasis patients are an important source of IFN-g, IL-13, IL-17, and IL-22. J. Invest. Dermatol. 133, 973-979 (2013).
55. Bowcock, A. M. et al. Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies. Hum. Mol. Genet. 10, 1793-1805 (2001).
56. Gottlieb, A. B., Luster, A. D., Posnett, D. N. & Carter, D. M. Detection of gamma interferon-induced protein IP10 in psoriatic plaques. J. Exp. Med. 168, 941-948 (1988).
57. Chen, S. C. et al. Expression of chemokine receptor CXCR3 by lymphocytes and plasmacytoid dendritic cells in human psoriatic lesions. Arch. Dermatol. Res. 302, 113-123 (2010).
58. Frasca, L. et al. IFN-gamma arms human dendritic cells to perform multiple effector functions. J. Immunol. 180, 1471-1481 (2008).
59. Johnson-Huang, L. M. et al. A single intradermal injection of IFN-g induces an inflammatory state in both non-lesional psoriatic and healthy skin. J. Invest. Dermatol. 132, 1177-1187 (2012).
60. Gunderson, A. J. et al. CD8() T cells mediate RAS-induced psoriasis-like skin inflammation through IFN-g. J. Invest. Dermatol. 133, 955-963 (2013).
61. Kastelan, M., Prpic-Massari, L. & Brajac, I. Apoptosis in Psoriasis. Acta dermatovenerol. Croat. 17, 182-186 (2009).
62. Wrone-Smith, T. et al. Keratinocytes derived from psoriatic plaques are resistant to apoptosis compared with normal skin. Am. J. Pathol. 151, 1321-1329 (1997).
63. Sigmundottit, H., Gudjónsson, J. E., Jónsdóttir, I., Lúdvksson, B. R. & Valdimarsson, H. The frequency of CLA CD8 T cells in the blood of psoriasis patients correlates closely with the severity of their disease. Clin. Exp. Immunol. 126, 365-369 (2001).
64. Seneviratne, S. L. et al. Interleukin-4 induced down-regulation of skin homing receptor expression by human viral specific CD8 T cells may contribute to atopic risk of cutaneous infection. Clin. Exp. Immunol. 11, 107-115 (2005).
65. Anderson, R. P. & Jabri, B. Vaccine against autoimmune disease: antigenspecific immunotherapy. Curr. Opin. Immunol. 25, 410-417 (2013).
66. Frasca, L. et al. Hypervariable region 1 variants act as TCR antagonists for hepatitis C virus-specific CD4 T cells. J. Immunol. 163, 650-658 (1999).
67. Baba, E. et al. N-linked carbohydrate on human leukocyte antigen-C and recognition by natural killer cell inhibitory receptors. Hum. Immunol. 61, 1202-1218 (2000).
68. Kavathas, P., Bach, F. H. & DeMars, R. Gamma ray-induced loss of expression of HLA and glyoxalase I alleles in lymphoblastoid cells. J. Invest. Dermatol. 117, 1546-1553 (2001).
69. Storkus, W. J., Alexander, J., Payne, J. A., Dawson, J. R. & Cresswell, P. Reversal of natural killing susceptibility in target cells expressing transfected class I HLA genes. Proc. Natl Acad. Sci. USA 86, 2361-2364 (1989).
70. Palazzo, R. et al. Use of whole-blood samples in in-house bulk and single-cell antigen-specific gamma interferon assays for surveillance of Mycobacterium tuberculosis infections. Clin. Vaccine Immunol. 15, 327-337 (2008).